{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T21:32:28Z","timestamp":1780695148568,"version":"3.54.1"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p><jats:italic>Cryptococcus<\/jats:italic> spp. is a complex species that often causes cryptococcosis, which is one of the most common opportunistic infections in adults living with HIV and has very high morbidity and mortality rates. This study aimed to investigate the antifungal susceptibility profiles and epidemiological characteristics of the <jats:italic>Cryptococcus neoformans<\/jats:italic> species complex (CNSC) and the <jats:italic>Cryptococcus gattii<\/jats:italic> species complex (CGSC) in Zhejiang Province, China. A total of 177 CNSC and 3 CGSC isolates were collected, and antifungal susceptibility was tested by FUNGUS 3 and verified with an E-test. Moreover, multiple classification methods and genomic analyses were performed. The majority of the isolates (96.11%) were <jats:italic>C<\/jats:italic>. <jats:italic>neoformans<\/jats:italic> (formerly <jats:italic>C<\/jats:italic>. <jats:italic>neoformans<\/jats:italic> var. <jats:italic>grubii<\/jats:italic>) (ST5-VNI-A-\u03b1). Our study highlights that most of the patients with cryptococcosis were non-HIV patients in China, and nearly half of them did not have underlying diseases that led to immune insufficiency. Most of the <jats:italic>Cryptococcus<\/jats:italic> spp. isolates in this study were sensitive to common antifungal drugs. Two 5-flucytosine (5-FC)-resistant strains were identified, and <jats:italic>FUR1<\/jats:italic> mutation was detected in the 5-FC-resistant isolates. Typing based on whole-genome sequencing (WGS) showed better discrimination than that achieved with multilocus sequence typing (MLST) and indicated a clear population structure. A phylogenetic analysis based on WGS included more genomic information than traditional classification methods.<\/jats:p>","DOI":"10.3389\/fmicb.2022.991703","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T04:29:54Z","timestamp":1668659394000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Antifungal susceptibility and molecular characteristics of Cryptococcus spp. based on whole-genome sequencing in Zhejiang Province, China"],"prefix":"10.3389","volume":"13","author":[{"given":"Junli","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunsong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"ref4","volume-title":"Fast QC: A quality control tool for high throughput sequence data","author":"Andrews","year":"2010"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/jof5030071","article-title":"Central nervous system Cryptococcal infections in non-HIV infected patients","volume":"5","author":"Beardsley","year":"2019","journal-title":"J. Fungi"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/myc.12747","article-title":"A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species","volume":"61","author":"Bongomin","year":"2018","journal-title":"Mycoses"},{"key":"ref1","article-title":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs for antifungal agents, version 10.0","year":"2020"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1038\/s41467-021-23745-1","article-title":"Moderate levels of 5-fluorocytosine cause the emergence of high frequency resistance in cryptococci","volume":"12","author":"Chang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1128\/JCM.38.5.2007-2009.2000","article-title":"Direct PCR of Cryptococcus neoformans MAT\u03b1 and MATa pheromones to determine mating type, Ploidy, and variety: a tool for epidemiological and molecular pathogenesis studies","volume":"38","author":"Chaturvedi","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"ref9","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition","year":"2008"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.fgb.2019.04.001","article-title":"Genotypes and population genetics of Cryptococcus neoformans and Cryptococcus gattii species complexes in Europe and the mediterranean area","volume":"129","author":"Cogliati","year":"2019","journal-title":"Fungal Genet. Biol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/mmy\/myaa047","article-title":"New multilocus sequence typing primers to enable genotyping of AD hybrids within the Cryptococcus neoformans species complex","volume":"58","author":"Cogliati","year":"2020","journal-title":"Med. Mycol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/PL00011265","article-title":"Flucytosine primary resistance in Candida species and Cryptococcus neoformans","volume":"20","author":"Cuenca-Estrella","year":"2001","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1101\/gr.218727.116","article-title":"Population genomics and the evolution of virulence in the fungal pathogen Cryptococcus neoformans","volume":"27","author":"Desjardins","year":"2017","journal-title":"Genome Res."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10096-014-2289-2","article-title":"Molecular epidemiology of Cryptococcus neoformans and Cryptococcus gattii in China between 2007 and 2013 using multilocus sequence typing and the Diversi lab system","volume":"34","author":"Dou","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e00342","DOI":"10.1128\/mBio.00342-10","article-title":"Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts","volume":"2","author":"D\u2019Souza","year":"2011","journal-title":"MBio"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"5898","DOI":"10.1128\/AAC.01115-12","article-title":"Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole","volume":"56","author":"Espinel-Ingroff","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref70","article-title":"Overview of antifungal ECOFFs and clinical breakpoints for yeasts, moulds and dermatophytes using the EUCAST E.Def 7.3, E.Def 9.4 and E.Def 11.0 procedures","year":"2022"},{"key":"ref16","first-page":"3047","article-title":"Multi QC: summarize analysis results for multiple tools and samples in a single report","volume-title":"J. Bioinform","author":"Ewels","year":"2016"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"887.e1-.e9","DOI":"10.1016\/j.cmi.2016.07.008","article-title":"Predominance of Cryptococcus neoformans var. grubii multilocus sequence type 5 and emergence of isolates with non-wild-type minimum inhibitory concentrations to fluconazole: a multi-Centre study in China","volume":"22","author":"Fan","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.fgb.2014.10.017","article-title":"Epidemiology of Cryptococcus and cryptococcosis in China","volume":"78","author":"Fang","year":"2015","journal-title":"Fungal Genet. Biol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bjid.2019.11.004","article-title":"Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017","volume":"24","author":"Fang","year":"2020","journal-title":"Braz. J. Infect. Dis."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e0004861","DOI":"10.1371\/journal.pntd.0004861","article-title":"MLST and whole-genome-based population analysis of Cryptococcus gattii VGIII links clinical, veterinary and environmental strains, and reveals divergent serotype specific sub-populations and distant ancestors","volume":"10","author":"Firacative","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1128\/AAC.00880-08","article-title":"Nonsense and missense mutations in FCY2 and FCY1 genes are responsible for flucytosine resistance and flucytosine-fluconazole cross-resistance in clinical isolates of Candida lusitaniae","volume":"53","author":"Florent","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/mmy\/myz089","article-title":"Microbiological and clinical characteristics of cryptococcemia: a retrospective analysis of 85 cases in a Chinese hospital","volume":"58","author":"Fu","year":"2020","journal-title":"Med. Mycol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/myc.12543","article-title":"Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain","volume":"60","author":"Gago","year":"2017","journal-title":"Mycoses."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1128\/AAC.00048-11","article-title":"Group for Enteric R, et al. trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002\u20132003 and 2007\u20132008","volume":"55","author":"Govender","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.fgb.2015.02.009","article-title":"Recognition of seven species in the Cryptococcus gattii\/Cryptococcus neoformans species complex","volume":"78","author":"Hagen","year":"2015","journal-title":"Fungal Genet. Biol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"683670","DOI":"10.3389\/fcimb.2021.683670","article-title":"Molecular markers reveal epidemiological patterns and evolutionary histories of the human pathogenic Cryptococcus","volume":"11","author":"Hong","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref27","first-page":"1762","article-title":"Mashtree: a rapid comparison of whole genome sequence files","volume-title":"J. Open Source Softw","author":"Katz","year":"2019"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e00357","DOI":"10.1128\/mSphere.00357-16","article-title":"The case for adopting the \u201cspecies complex\u201d nomenclature for the etiologic agents of cryptococcosis","volume":"2","author":"Kwon-Chung","year":"2017","journal-title":"mSphere."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s12072-021-10239-x","article-title":"APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy","volume":"15","author":"Lau","year":"2021","journal-title":"Hepatol. Int."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1534\/g3.111.001255","article-title":"Genetic diversity and genomic plasticity of Cryptococcus neoformans AD hybrid strains","volume":"2","author":"Li","year":"2012","journal-title":"G3"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/j.1469-0691.2009.02930.x","article-title":"Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility","volume":"16","author":"Liaw","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3760\/cma.j.issn.0578-1426.2018.05.003","article-title":"Expert consensus on the diagnosis and treatment of cryptococcal meningitis","volume":"57","author":"Liu","year":"2018","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1126\/science.1103773","article-title":"The genome of the basidiomycetous yeast and human pathogen Cryptococcus neoformans","volume":"307","author":"Loftus","year":"2005","journal-title":"Science"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrmicro.2015.6","article-title":"Cryptococcus: from environmental saprophyte to global pathogen","volume":"14","author":"May","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/13693780902953886","article-title":"Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii","volume":"47","author":"Meyer","year":"2009","journal-title":"Med. Mycol."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3390\/jof7040260","article-title":"Associations between Cryptococcus genotypes, phenotypes, and clinical parameters of human disease: A Review","volume":"7","author":"Montoya","year":"2021","journal-title":"J. Fungi"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/jof3040067","article-title":"HIV-associated Cryptococcal disease in resource-limited settings: a case for \"prevention is better than cure\"?","volume":"3","author":"Oladele","year":"2017","journal-title":"J. Fungi"},{"key":"ref38","unstructured":"Rapid advice: Diagnosis2011"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1128\/AAC.00824-06","article-title":"Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance","volume":"51","author":"Papon","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/acr.22628","article-title":"Herpes zoster reactivation in patients with rheumatoid arthritis: analysis of disease characteristics and disease-modifying Antirheumatic drugs","volume":"67","author":"Pappas","year":"2015","journal-title":"Arthritis Care Res."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S1473-3099(11)70245-6","article-title":"Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomized, placebo-controlled trial","volume":"11","author":"Parkes-Ratanshi","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref43","volume-title":"Performance standards for antifungal susceptibility of testing yeasts","year":"2018"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1128\/AAC.47.11.3653-3656.2003","article-title":"G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate","volume":"47","author":"Rodero","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.meegid.2018.10.011","article-title":"Hybrids and hybridization in the Cryptococcus neoformans and Cryptococcus gattii species complexes","volume":"66","author":"Samarasinghe","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e1001343","DOI":"10.1371\/journal.ppat.1001343","article-title":"Low diversity Cryptococcus neoformans variety Grubii multilocus sequence types from Thailand are consistent with an ancestral African origin","volume":"7","author":"Simwami","year":"2011","journal-title":"PLoS Pathog."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1128\/AAC.05502-11","article-title":"Identification of a Cryptococcus neoformans cytochrome P 450 lanosterol 14alpha-demethylase (erg 11) residue critical for differential susceptibility between fluconazole\/voriconazole and itraconazole\/posaconazole","volume":"56","author":"Sionov","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1128\/CMR.8.4.515","article-title":"Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans","volume":"8","author":"T G Mitchell","year":"1995","journal-title":"Clin. Microbiol. Rev."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s11046-012-9528-9","article-title":"Comparative analysis of the Vitek 2 antifungal susceptibility system and E-test with the CLSI M27-A3 broth microdilution method for susceptibility testing of Indian clinical isolates of Cryptococcus neoformans","volume":"173","author":"Tewari","year":"2012","journal-title":"Mycopathologia"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/mmy\/myy105","article-title":"Multilocus sequence typing of Cryptococcus neoformans var. Grubii from Laos in a regional and global context","volume":"57","author":"Thanh","year":"2019","journal-title":"Med. Mycol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/jac\/dkm247","article-title":"In vitro susceptibilities to yeasts using the ATB FUNGUS 2 method, compared with Sensititre yeast one and standard CLSI (NCCLS) M27-A2 methods","volume":"60","author":"Torres-Rodriguez","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1128\/JCM.01130-12","article-title":"In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance net (CHIF-NET) study","volume":"50","author":"Wang","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrneurol.2016.167","article-title":"Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy","volume":"13","author":"Williamson","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s11046-020-00456-7","article-title":"Multi-locus sequence typing and whole genome sequence analysis of Cryptococcus neoformans isolated from clinical specimens in Vajira hospital, Bangkok, Thailand","volume":"185","author":"Wongsuk","year":"2020","journal-title":"Mycopathologia"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/myc.12312","article-title":"Molecular characterization of clinical Cryptococcus neoformans and Cryptococcus gattii isolates from Sichuan province","volume":"58","author":"Wu","year":"2015","journal-title":"China. Mycoses."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.2147\/IDR.S173805","article-title":"Five-year China hospital invasive fungal surveillance net (CHIF-NET) study of invasive fungal infections caused by non-candidal yeasts: species distribution and azole susceptibility","volume":"11","author":"Xiao","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1567-1364.2008.00422.x","article-title":"Genotypeandmating typeanalysis of Cryptococcusneoformans and Cryptococcusgattii isolates from China thatmainlyoriginated fromnon-HIV-infectedpatients","volume":"8","author":"Xiaobo Feng","year":"2008","journal-title":"FEMS Yeast Res."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"e0010078","DOI":"10.1371\/journal.pntd.0010078","article-title":"Molecular epidemiology and microbiological characteristics of Cryptococcus gattii VGII isolates from China","volume":"16","author":"Zang","year":"2022","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3389\/fmicb.2019.00691","article-title":"The fungal CYP51s: their functions, structures, related drug resistance, and inhibitors","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/myc.13261","article-title":"Clinical features and outcomes of Cryptococcemia patients with and without HIV infection","volume":"64","author":"Zhao","year":"2021","journal-title":"Mycoses"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.3201\/eid2609.200016","article-title":"Risk-based estimate of human fungal disease burden, China","volume":"26","author":"Zhou","year":"2020","journal-title":"Emerg Infect Dis."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"942940","DOI":"10.3389\/fmicb.2022.942940","article-title":"Molecular epidemiology and antifungal resistance of Cryptococcus neoformans from human immunodeficiency virus-negative and human immunodeficiency virus-positive patients in eastern China","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3109\/13693780903437876","article-title":"Cryptococcal meningitis in non-HIV-infected patients in a Chinese tertiary care hospital, 1997\u20132007","volume":"48","author":"Zhu","year":"2010","journal-title":"Med. Mycol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.991703\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T04:30:03Z","timestamp":1668659403000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.991703\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":64,"alternative-id":["10.3389\/fmicb.2022.991703"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.991703","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]},"article-number":"991703"}}